Sign In
Buy PFE
$26.04
+0.350 (+1.36%)
At Close: Jun 05, 2026
What To Expect From Pfizer's Q4?
07:00am, Friday, 27'th Jan 2023
Its Covid-19 vaccine and the antiviral pill will likely contribute a little over $12 billion to its top line, aligning with prior-year quarter's sales.
FDA has not observed stroke risk among seniors who received Pfizer booster after extensive review
12:27pm, Thursday, 26'th Jan 2023
Preliminary CDC data indicated a possible stroke risk following simultaneous administration of the Pfizer Covid booster and the flu vaccine.
Analyst: Pfizer's Covid Estimates Need to Drop
09:06am, Thursday, 26'th Jan 2023
UBS downgraded Pfizer Inc. (NYSE:PFE) to "neutral" from "buy" this morning, citing lower Covid-19 expectations.
Can Pfizer (PFE) Beat Expectations This Earnings Season?
09:02am, Thursday, 26'th Jan 2023
Higher alliance revenues from Eliquis, higher sales of Prevnar vaccines and drugs like Vyndaqel/Vyndamax are likely to have contributed to Pfizer's (PFE) sales growth in Q4.
10 Biggest Companies Reporting Earnings in the First Week of Feb 2023
10:56pm, Wednesday, 25'th Jan 2023
The fourth quarter earnings season for the S&P 500 didn't get off to a strong start.
7 Cream-of-the-Crop Stocks to Buy Today
05:00pm, Wednesday, 25'th Jan 2023
Investors are scurrying to find stocks to buy as the market stages a strong uptrend this year. Of course, people make money when prices go up.
Gemba, a corporate VR training platform used by Coca-Cola and Pfizer, raises $18M
04:00am, Wednesday, 25'th Jan 2023
Gemba, an enterprise-focused virtual reality (VR) training startup used by some of the world's biggest companies, has raised $18 million in a Series A round of funding.
When Does Pfizer Become A Bargain?
11:46am, Tuesday, 24'th Jan 2023
The pharmaceutical company Pfizer Inc. (NYSE: PFE) saw its shares become very popular after creating one of the top vaccines to fight COVID-19 back in the day. But as the pandemic has started to fade
Pfizer (PFE) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release
11:17am, Tuesday, 24'th Jan 2023
Pfizer (PFE) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Ex-Dividend Reminder: Pfizer, Unum Group And Signature Bank
10:15am, Tuesday, 24'th Jan 2023
On 1/26/23, Pfizer, Unum Group, and Signature Bank will all trade ex-dividend for their respective upcoming dividends. Pfizer Inc will pay its quarterly dividend of $0.41 on 3/3/23, Unum Group will pa
3 Stocks to Buy With a Forward P/E of Less Than 10
11:39am, Monday, 23'rd Jan 2023
Among various techniques to screen stocks to buy, the price-earnings ratio is a good indicator to consider. In simple terms, it's the amount an investor is willing to pay in the market for every dolla
Pfizer And L3Harris: 2 Recession-Resistant Companies Worth Considering
04:47pm, Friday, 20'th Jan 2023
After the S&P rebounded nicely from its September/October low, it seems that solid value opportunities are no longer available - a closer look shows that this is not the case. With a recession looming
Moderna and Pfizer Race to Release RSV Vaccines
10:14am, Friday, 20'th Jan 2023
Two of the largest vaccine producers have engaged in the rapid development of RSV vaccines, here's how the companies are tracking so far.
2 Healthcare Stocks You Can Buy and Hold for the Next Decade
09:15am, Friday, 20'th Jan 2023
The healthcare industry isn't going anywhere.
Pharmaceutical Stocks Pfizer, GSK, Moderna Come Close To Cracking A Multibillion-Dollar RSV Vaccine Market
01:41pm, Thursday, 19'th Jan 2023
Big Pharma stalwarts are on the brink of launching the first-ever RSV vaccines, potentially enriching the pharmaceutical stocks. The post Pharmaceutical Stocks Pfizer, GSK, Moderna Come Close To Crack
